References
- Chlebowski RT, Schwartz AG, Wakelee H, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243–51
- Chlebowski RT, Anderson GL, Manson JE, et al. Lung cancer among postmenopausal women treated with estrogen alone in the Women's Health Initiative randomized trial. J Natl Cancer Inst 2010 Aug 13. Epub ahead of print
- Rodriguez C, Spencer Feigelson H, Deka A, et al. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008;17:655–60
- Ayeni O, Robinson A. Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed? Curr Oncol 2009;16:21–25
- Meinhold CL, Berrington de González A, Bowman ED, et al. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer. Int J Cancer 2010 May 4. Epub ahead of print
- Ganti AK, Sahmoun AE, Panwalker AW, et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59–63
- Slatore CG, Chien JW, Au DH, et al. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010;28:1540–6
- Patel JD. Lung cancer: a biologically different disease in women? Womens Health (Lond Engl) 2009;5:685–91